首页 | 本学科首页   官方微博 | 高级检索  
     

肝脾T细胞淋巴瘤的研究进展
引用本文:马银娟1,' target='_blank'>2,王 莹1,杨 柯1,潘耀柱1,王 璇1. 肝脾T细胞淋巴瘤的研究进展[J]. 现代肿瘤医学, 2021, 0(13): 2343-2347. DOI: 10.3969/j.issn.1672-4992.2021.13.032
作者姓名:马银娟1  ' target='_blank'>2  王 莹1  杨 柯1  潘耀柱1  王 璇1
作者单位:1.中国人民解放军联勤保障部队第九四〇医院,甘肃 兰州 730050;2.宁夏医科大学研究生院,宁夏 银川 750004
基金项目:National Natural Science Foundation of China(No.81372132);国家自然科学基金(编号:81372132)
摘    要:肝脾T细胞淋巴瘤(HSTCL)是一种罕见的特殊类型的侵袭性外周T细胞淋巴瘤,主要表现为发热、盗汗、体重减轻及腹痛,多累及脾、肝和骨髓,通常无淋巴结肿大。因HSTCL具有异质性及侵袭性,其预后极差。目前有关HSTCL治疗的文献多数出自个案报告,缺乏随机前瞻性试验,因此暂无统一的一线疗法,大剂量化疗诱导联合异基因造血干细胞移植的方案目前较受认可。由于此病罕见且研究相对较少,本文回顾相关文献将HSTCL的病因、发病机制、临床表现及诊断治疗做一综述。

关 键 词:肝脾T细胞淋巴瘤  肝脾γδ-T细胞淋巴瘤  肝脾αβ-T细胞淋巴瘤  造血干细胞移植

Recent advances in hepatosplenic T-cell lymphoma
MA Yinjuan1,' target='_blank'>2,WANG Ying1,YANG Ke1,PAN Yaozhu1,WANG Xuan1. Recent advances in hepatosplenic T-cell lymphoma[J]. Journal of Modern Oncology, 2021, 0(13): 2343-2347. DOI: 10.3969/j.issn.1672-4992.2021.13.032
Authors:MA Yinjuan1  ' target='_blank'>2  WANG Ying1  YANG Ke1  PAN Yaozhu1  WANG Xuan1
Affiliation:1.The 940th Hospital of the PLA Joint Service Support Force,Gansu Lanzhou 730050,China;2.Graduate School of Ningxia Medical University,Ningxia Yinchuan 750004,China.
Abstract:Hepatosplenic T-cell lymphoma(HSTCL) is a rare special type of aggressive peripheral T cell lymphoma.The main symptoms of the patients are fever,night sweats,weight loss,and abdominal pain,and extranodal lymphatic tissue infiltration such as the spleen,liver,and bone marrow,usually without lymph node enlargement.Due to the heterogeneity and aggressiveness of HSTCL,its prognosis is extremely poor.At present,most of the literature of HSTCL therapy experience is mostly based on case reports,and randomized prospective trials are limited by its rarity.Therefore,there is no unified first-line therapy at present,and the regimen of high-dose inducing chemotherapy combined with allogeneic hematopoietic stem cell transplantation is currently well accepted now.And due to the rarity of HSTCL and relatively few studies,the etiology,pathogenesis,clinical manifestations,diagnosis and treatment of HSTCL are reviewed in this paper.
Keywords:hepatosplenic T-cell lymphoma   hepatosplenic γδ-T cell lymphoma   hepatosplenic αβ-T cell lymphoma   hematopoietic stem cell transplantation
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号